OTR4132-MD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OTR4132-MD, covering 2024-11-26 to 2024-11-26. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke [Phase 2]